Recent studies illuminate promising cancer therapies including an ethanolic extract from marine diatom Chaetoceros socialis inducing apoptosis in prostate and glioblastoma cells, and stilbenes—plant polyphenols—targeting tumor progression through diverse molecular mechanisms. Another study reports a bispecific affitoxin engineered to target HPV E7 proteins, improving cervical cancer treatment. These multidisciplinary investigations advance novel approaches from natural products to bioengineered agents, enriching the therapeutic arsenal against various malignancies.